Before it constructed a new manufacturing facility, Chief Business Officer Mark Cochran says
Microbix was operating at capacity. Now that the facility is operational, the company is
reporting record sales,
showing a 17 per cent increase in the second quarter of this year.
Cochran says the 20-year-old company has been seeing growth of about
20 per cent per year, and expects to continue that trend for the next
three to four years until they reach capacity again.
Microbix is
a biotechnology company headquartered in Etobicoke, Ontario, focusing
on virology and biological technologies. In a news release announcing
its quarterly results, the company attributed its sales growth to the
new facility as well as to a newly release diagnostic product used in
US hospitals and to higher royalties from the company's rabies vaccine.
Cochran
says the company is growing its staff to keep up. He estimates that
Microbix has hired "three or four" new employees in the past quarter,
and may "add another 10 positions in the next year."
Writer: Edward Keenan
Source: Mark Cochran, Chief Business Officer, Microbix
Got an Innovation & Job News tip? Email [email protected].